Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Ken W who wrote (1943)	3/19/1998 9:54:00 AM
From: Amigo Mike	Respond to of 29382

NEW PICK ..... the Amigos have purchased ROIX at this morning. The Amigos have decided to add ROIX - Response Oncology to the Amigofolio today. RESPONSE ONCOLOGY INC. is a comprehensive cancer management company which owns and/or operates a network of outpatient treatment centers or IMPACT(R) (IMPlementing Advanced Cancer Treatments) Centers, which provide stem cell supported high-dose chemotherapy and other advanced cancer treatment services under the direction of practicing oncologists; owns the assets of and manages oncology practices; and conducts clinical cancer research on behalf of pharmaceutical manufacturers. At present, ROIX insiders own 73% .... institutions own approx 25%. Total shares out ~12 million. FLOAT ONLY ~1.3 million. ROIX is expected to earn .48 per share this year. An analyst recently upped estimates to .52. Two strong buys on ROIX currently. The Amigos expect double digits in the near term as healthcare stocks are gaining strength. ROIX chart reflects that strength as does recent increase in trading volume. Amigo Mike